Prokidney Corp.

09/03/2024 | Press release | Distributed by Public on 09/03/2024 05:41

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S.